These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 22179400
1. Sotrastaurin (AEB071) alone and in combination with cyclosporine A prolongs survival times of non-human primate recipients of life-supporting kidney allografts. Bigaud M, Wieczorek G, Beerli C, Audet M, Blancher A, Heusser C, Morris RE, Wagner J. Transplantation; 2012 Jan 27; 93(2):156-64. PubMed ID: 22179400 [Abstract] [Full Text] [Related]
2. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720. Weckbecker G, Pally C, Beerli C, Burkhart C, Wieczorek G, Metzler B, Morris RE, Wagner J, Bruns C. Transpl Int; 2010 May 01; 23(5):543-52. PubMed ID: 20003043 [Abstract] [Full Text] [Related]
3. Overview of sotrastaurin clinical pharmacokinetics. Kovarik JM, Slade A. Ther Drug Monit; 2010 Oct 01; 32(5):540-3. PubMed ID: 20683390 [Abstract] [Full Text] [Related]
4. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival. Fang YH, Joo DJ, Lim BJ, Huh KH, Kim MS, Suh H, Kim YS. J Surg Res; 2011 Nov 01; 171(1):e133-7. PubMed ID: 21816421 [Abstract] [Full Text] [Related]
6. Sotrastaurin and cyclosporine drug interaction study in healthy subjects. Kovarik JM, Stitah S, Slade A, Vitaliti A, Straube F, Grenet O, Winter S, Sfikas N, Seiberling M. Biopharm Drug Dispos; 2010 Jul 01; 31(5-6):331-9. PubMed ID: 20578209 [Abstract] [Full Text] [Related]
7. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats. Merani S, Pawlick RL, Edgar RL, Toso C, Emamaullee J, Anderson CC, Shapiro AM. Transplantation; 2009 Jan 15; 87(1):59-65. PubMed ID: 19136892 [Abstract] [Full Text] [Related]
8. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys. Hausen B, Klupp J, Christians U, Higgins JP, Baumgartner RE, Hook LE, Friedrich S, Celnicker A, Morris RE. Transplantation; 2001 Sep 27; 72(6):1128-37. PubMed ID: 11579312 [Abstract] [Full Text] [Related]
9. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Huang WH, Yan Y, De Boer B, Bishop GA, House AK. Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161 [Abstract] [Full Text] [Related]
10. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI, Cofer BR, Davies C, Alexander JW. Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575 [Abstract] [Full Text] [Related]
11. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A. Transplantation; 2006 Jun 15; 81(11):1568-76. PubMed ID: 16770246 [Abstract] [Full Text] [Related]
12. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W, Xie L, Wang S. Zhonghua Yan Ke Za Zhi; 2002 Aug 15; 38(8):502-5. PubMed ID: 12410993 [Abstract] [Full Text] [Related]
13. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys. Yang H, Chen G, Kanai N, Shum J, Garcia B, Huang X, Min W, Luo Y, Dutartre P, Zhong R. Transplantation; 2003 Apr 27; 75(8):1166-71. PubMed ID: 12717197 [Abstract] [Full Text] [Related]
14. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K. Transplantation; 2008 Jan 27; 85(2):179-84. PubMed ID: 18212621 [Abstract] [Full Text] [Related]
15. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss? He X, Johnston A. Transplant Proc; 2004 Jun 27; 36(5):1321-6. PubMed ID: 15251323 [Abstract] [Full Text] [Related]
16. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E. Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352 [Abstract] [Full Text] [Related]
17. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients. Xue W, Ding X, Tian P, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X. Ren Fail; 2010 Jan 27; 32(3):314-9. PubMed ID: 20370446 [Abstract] [Full Text] [Related]
18. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. Tanaka M, Mokhtari GK, Balsam LB, Cooke DT, Kofidis T, Zwierzchonievska M, Robbins RC. J Heart Lung Transplant; 2005 Apr 27; 24(4):446-53. PubMed ID: 15797747 [Abstract] [Full Text] [Related]
19. Significant prolongation of animal survival by combined therapy of FR167653 and cyclosporine A in rat renal allografts. Azuma H, Wada T, Gotoh R, Furuichi K, Sakai N, Yazawa K, Yokoyama H, Katsuoka Y, Takahara S. Transplantation; 2003 Oct 15; 76(7):1029-36. PubMed ID: 14557748 [Abstract] [Full Text] [Related]
20. AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report. Fang YH, Joo DJ, Lim BJ, Kim JY, Kim MS, Jeong HJ, Kim YS. Transplant Proc; 2010 Apr 15; 42(3):976-9. PubMed ID: 20430219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]